ClinConnect ClinConnect Logo
Search / Trial NCT05918601

Peer-led Personalized Support Program

Launched by CHINESE UNIVERSITY OF HONG KONG · Jun 15, 2023

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

Health Risk Behaviours Drug Abuse

ClinConnect Summary

This clinical trial is studying a new support program designed to help young people who have been struggling with drug abuse. The program uses instant messaging to connect participants with trained peer supporters who can provide personalized guidance and encouragement. The goal is to see if this approach can help participants quit using drugs and improve their overall quality of life over a year.

To join the study, participants need to be 35 years old or younger, speak Cantonese, and have a history of drug abuse within the last year. Peer supporters, who will also be involved in the program, must be between 18 and 35 years old, have a medical background, and complete specific training. Throughout the trial, participants can expect to receive support from peers who understand their challenges, and the study aims to find out if this kind of help makes a real difference in their recovery journey.

Gender

ALL

Eligibility criteria

  • The inclusion criteria of target service group (drug abusers) for this programme:
  • be aged 35 or below
  • be able to communicate in Cantonese
  • have an history of drug abuse within the past 12 months (including all types of drugs such as narcotics analgesics, hallucinogens, depressants, stimulants, tranquillizers and other recreational drugs)
  • The exclusion Criteria of target service group (drug abusers) for this programme:
  • psychologically or physically unable to communicate
  • The inclusion criteria of peer supporters:
  • be aged 18 - 35
  • be able to communicate in Cantonese
  • have a medical background
  • complete the training courses and pass the evaluation of peer supporter qualification
  • The exclusion Criteria of peer supporters:
  • psychologically or physically unable to communicate

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Ho Cheung William Li

Principal Investigator

Chinese University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported